4
Changes in Ownership
PharmaCyte Biotech, Inc. Filed Acc 0001683168-26-002633
Options or other derivatives
- Director acquired 119,170 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| WEINSTEIN ROBERT Director | 2026-03-31 | Grant or award · Stock Option (Right to Buy) | +119,170 | 119,170 | D: show line 1 in the form |
Loading xslF345X06/ownership.xml…